[Drug added therapeutic value: what is it, how is it assessed and what should be it's role in pharmaceutical policy?].
Soto Alvarez
J
J
Departamento de Farmacoepidemiología y Farmacoeconomía, Unidad Médica, Pfizer S.A., Alcobendas, Madrid. javier.soto.alvarez@pfizer.com
D007880:Legislation, Drug; D011050:Policy Making; D013030:Spain